Oak Grove Capital’s Chemours CC Stock Holding History

Oak Grove Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	–	–	79
2018 Q3	$0	Hold	1	–	–	﹤0.01%	160
2018 Q2	$0	Hold	1	–	–	﹤0.01%	161
2018 Q1	$0	Buy	+1	New	+$50	﹤0.01%	170

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Oak Grove Capital's CC Position: Q4 2018 in Review

Oak Grove Capital sold out of Chemours (CC) in Q4 2018, closing a stake of 1 share.

Oak Grove Capital first reported a position in CC in Q1 2018 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 506 funds tracked by Wall St. Rank hold CC as of Q4 2018.

Oak Grove Capital reported no remaining Chemours position as of Q4 2018 after selling out during the quarter.
Oak Grove Capital sold 1 Chemours share in Q4 2018.
Oak Grove Capital first reported a position in Chemours in Q1 2018 and held it in 3 quarters.
Oak Grove Capital's Chemours position peaked at $0 in Q3 2018.
506 funds tracked by Wall St. Rank held Chemours as of Q4 2018.

Based on Oak Grove Capital's 13F filing for Q4 2018, filed 15 Feb 2019.